Illumina Plans Suite of Focused Genotyping Chips, Sees Slight Delay in 'Resurgence' of GWAS Market
September 14, 2010
Illumina Plans Suite of Focused Genotyping Chips, Sees Slight Delay in 'Resurgence' of GWAS Market
Illumina is preparing to launch more focused whole-genome genotyping arrays for use in genome-wide association studies, even as it gathers content for its next major BeadChip release, the Omni5, which is scheduled to launch next year.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Illumina Predicts Flat Future for Array Business as GWAS Decline Counters Growth in New Markets
October 30, 2012 / BioArray News - Large-Scale Metabochip Studies ID New Susceptibility Loci for Glycemic Traits and Diabetes
August 28, 2012 / BioArray News - Illumina CEO 'Optimistic' about Array Business as Q1 Sales Spike 47 Percent
May 3, 2011 / BioArray News - 'Soft' Q1 Pushes Affymetrix to Bet on Applied Markets, Acquisitions to Restore Growth
May 3, 2011 / BioArray News - Sirius Genomics Taps Golden Helix for GWAS Analysis, Companion Dx Co-development
October 19, 2010 / BioArray News